ARIAD Pharma (ARIA) Misses Q3 EPS by 6c

Go back to ARIAD Pharma (ARIA) Misses Q3 EPS by 6c

ARIAD Reports Third Quarter 2015 Financial Results and Progress on Strategic Objectives

November 3, 2015 7:35 AM EST

Conference Call Scheduled Today at 8:30 a.m. ET

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the third quarter of 2015, including revenue from sales of... More